1. FDA, Department of Health and Human Services of the USA (1992) FDA’s Policy Statement for the Development of New Stereoisomeric Drugs, Federal Register, 2 May 1992 57:22, 102
2. Effenberger F (1994) Angew Chem 106:1609
3. Angew Chem Int Ed Engl 33:1555
4. Stinson SC (1995) Chem Eng News 73:44
5. Collins AN, Sheldrake GN, Crosby J (1997) Chirality in industry II. Wiley, New York